Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) — Financial Flexibility Index
Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) has a Financial Flexibility Index of 0.16x as of September 2025. Free cash flow of CN¥170.19 Million (operating CF CN¥88.00 Million minus capex CN¥82.19 Million) represents 0% of total liabilities (CN¥1.04 Billion). Also explore 002317 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Guangdong Zhongsheng Pharmaceutical Co Ltd Financial Flexibility Index (2006–2024)
Historical Financial Flexibility Index trend for Guangdong Zhongsheng Pharmaceutical Co Ltd across 19 annual periods. Check how strategically is Guangdong Zhongsheng Pharmaceutical Co L's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Guangdong Zhongsheng Pharmaceutical Co Ltd (2006–2024)
Year-by-year free cash flow to debt coverage for Guangdong Zhongsheng Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see how much is Guangdong Zhongsheng Pharmaceutical Co L worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.37x | CN¥566.10 Million | CN¥337.84 Million | CN¥1.54 Billion | ▲ +28.0% |
| 2023 | 0.29x | CN¥553.67 Million | CN¥190.61 Million | CN¥1.93 Billion | ▲ +69.5% |
| 2022 | 0.17x | CN¥331.03 Million | CN¥63.07 Million | CN¥1.96 Billion | ▼ -72.4% |
| 2021 | 0.61x | CN¥836.53 Million | CN¥622.77 Million | CN¥1.36 Billion | ▲ +140.4% |
| 2020 | 0.26x | CN¥293.37 Million | CN¥138.93 Million | CN¥1.15 Billion | ▼ -7.7% |
| 2019 | 0.28x | CN¥379.49 Million | CN¥251.16 Million | CN¥1.37 Billion | ▼ -23.9% |
| 2018 | 0.36x | CN¥470.26 Million | CN¥326.78 Million | CN¥1.29 Billion | ▼ -17.2% |
| 2017 | 0.44x | CN¥494.19 Million | CN¥369.91 Million | CN¥1.13 Billion | ▼ -26.6% |
| 2016 | 0.60x | CN¥479.47 Million | CN¥338.28 Million | CN¥801.23 Million | ▲ +172.6% |
| 2015 | 0.22x | CN¥268.82 Million | CN¥192.25 Million | CN¥1.22 Billion | ▼ -70.2% |
| 2014 | 0.74x | CN¥300.14 Million | CN¥100.60 Million | CN¥407.63 Million | ▼ -21.4% |
| 2013 | 0.94x | CN¥222.85 Million | CN¥110.95 Million | CN¥238.04 Million | ▼ -35.9% |
| 2012 | 1.46x | CN¥219.80 Million | CN¥142.38 Million | CN¥150.41 Million | ▼ -47.2% |
| 2011 | 2.77x | CN¥255.96 Million | CN¥70.56 Million | CN¥92.54 Million | ▲ +66.5% |
| 2010 | 1.66x | CN¥158.74 Million | CN¥91.72 Million | CN¥95.53 Million | ▲ +45.7% |
| 2009 | 1.14x | CN¥123.73 Million | CN¥100.89 Million | CN¥108.46 Million | ▲ +76.1% |
| 2008 | 0.65x | CN¥92.35 Million | CN¥72.86 Million | CN¥142.53 Million | ▲ +44.4% |
| 2007 | 0.45x | CN¥75.02 Million | CN¥49.35 Million | CN¥167.17 Million | ▲ +147.3% |
| 2006 | 0.18x | CN¥27.75 Million | CN¥17.91 Million | CN¥152.93 Million | — |